Lincoln Pharmaceuticals has informed that it enclosed copies of newspaper intimation with respect to the unaudited (standalone & Consolidated) Financial Results of the Company for the Quarter Ended 30 June, 2026.
The above information is a part of company’s filings submitted to BSE.